Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Long Noncoding | 2 | 2022 | 5 | 0.880 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2023 | 13 | 0.790 |
Why?
|
| Endothelial Cells | 10 | 2017 | 37 | 0.780 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 7 | 2017 | 24 | 0.620 |
Why?
|
| Lung | 8 | 2017 | 76 | 0.480 |
Why?
|
| Capillary Permeability | 5 | 2013 | 12 | 0.460 |
Why?
|
| Cell Membrane | 3 | 2013 | 63 | 0.460 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2013 | 7 | 0.460 |
Why?
|
| Pulmonary Artery | 3 | 2022 | 18 | 0.450 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 2013 | 4 | 0.400 |
Why?
|
| Ceramides | 1 | 2013 | 6 | 0.400 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2013 | 9 | 0.400 |
Why?
|
| Enzyme Activation | 1 | 2013 | 64 | 0.400 |
Why?
|
| Animals | 17 | 2021 | 2092 | 0.380 |
Why?
|
| Mice | 13 | 2021 | 760 | 0.370 |
Why?
|
| Sex Characteristics | 2 | 2022 | 64 | 0.330 |
Why?
|
| Endothelium, Vascular | 3 | 2015 | 15 | 0.320 |
Why?
|
| Hypertension, Pulmonary | 3 | 2017 | 13 | 0.260 |
Why?
|
| Nitric Oxide | 2 | 2005 | 36 | 0.240 |
Why?
|
| Intercellular Junctions | 1 | 2005 | 6 | 0.230 |
Why?
|
| Nitric Oxide Synthase | 1 | 2005 | 21 | 0.230 |
Why?
|
| Humans | 11 | 2023 | 12240 | 0.210 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2023 | 5 | 0.200 |
Why?
|
| Endocytosis | 4 | 2015 | 10 | 0.190 |
Why?
|
| Mice, Knockout | 6 | 2021 | 170 | 0.190 |
Why?
|
| Disease Models, Animal | 3 | 2021 | 338 | 0.190 |
Why?
|
| RNA, Small Interfering | 3 | 2017 | 45 | 0.180 |
Why?
|
| Caveolae | 4 | 2015 | 9 | 0.180 |
Why?
|
| Sex Chromosomes | 1 | 2022 | 2 | 0.180 |
Why?
|
| Lung Diseases | 2 | 2017 | 13 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2015 | 20 | 0.130 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2015 | 15 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 2 | 2019 | 22 | 0.130 |
Why?
|
| Pyridones | 1 | 2017 | 7 | 0.130 |
Why?
|
| ets-Domain Protein Elk-1 | 2 | 2017 | 4 | 0.130 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2017 | 27 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2017 | 90 | 0.130 |
Why?
|
| Vascular Remodeling | 1 | 2017 | 2 | 0.130 |
Why?
|
| Female | 4 | 2022 | 6974 | 0.120 |
Why?
|
| Bone and Bones | 1 | 2017 | 83 | 0.120 |
Why?
|
| Knee Injuries | 1 | 2017 | 69 | 0.120 |
Why?
|
| Basal Ganglia | 1 | 2015 | 6 | 0.120 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 18 | 0.110 |
Why?
|
| Cartilage, Articular | 1 | 2017 | 163 | 0.110 |
Why?
|
| Scavenger Receptors, Class B | 1 | 2015 | 2 | 0.110 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2015 | 3 | 0.110 |
Why?
|
| Cerebral Hemorrhage | 1 | 2015 | 37 | 0.110 |
Why?
|
| Microscopy, Fluorescence | 2 | 2013 | 43 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 205 | 0.110 |
Why?
|
| Osteoarthritis, Knee | 1 | 2017 | 169 | 0.110 |
Why?
|
| beta Catenin | 1 | 2015 | 42 | 0.110 |
Why?
|
| Smad2 Protein | 1 | 2015 | 2 | 0.110 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2015 | 3 | 0.110 |
Why?
|
| Smoking | 1 | 2015 | 84 | 0.110 |
Why?
|
| Platelet Activating Factor | 1 | 2013 | 5 | 0.100 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 14 | 0.100 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2013 | 6 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2013 | 29 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2013 | 78 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2013 | 125 | 0.100 |
Why?
|
| Liposomes | 1 | 2013 | 11 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 171 | 0.100 |
Why?
|
| Indoles | 2 | 2019 | 21 | 0.090 |
Why?
|
| Male | 7 | 2021 | 6815 | 0.090 |
Why?
|
| Dynamin II | 1 | 2011 | 2 | 0.090 |
Why?
|
| Microscopy, Electron | 2 | 2013 | 35 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 3 | 2015 | 26 | 0.080 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2005 | 6 | 0.070 |
Why?
|
| Rats | 3 | 2019 | 407 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2015 | 97 | 0.070 |
Why?
|
| Blood-Air Barrier | 1 | 2007 | 1 | 0.060 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2007 | 4 | 0.060 |
Why?
|
| Guanine Nucleotide Dissociation Inhibitors | 1 | 2007 | 2 | 0.060 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2007 | 6 | 0.060 |
Why?
|
| Caveolin 1 | 1 | 2005 | 4 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2005 | 5 | 0.060 |
Why?
|
| Albumins | 1 | 2005 | 4 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2005 | 9 | 0.060 |
Why?
|
| Organometallic Compounds | 1 | 2005 | 11 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 26 | 0.060 |
Why?
|
| CD11b Antigen | 1 | 2005 | 3 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2005 | 75 | 0.060 |
Why?
|
| Neutrophil Infiltration | 1 | 2005 | 3 | 0.060 |
Why?
|
| Neutrophils | 1 | 2005 | 58 | 0.050 |
Why?
|
| Sepsis | 1 | 2005 | 38 | 0.050 |
Why?
|
| Cell Line | 2 | 2015 | 150 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2003 | 45 | 0.050 |
Why?
|
| Up-Regulation | 1 | 2021 | 89 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2015 | 275 | 0.040 |
Why?
|
| Pyrroles | 1 | 2019 | 15 | 0.040 |
Why?
|
| Hypoxia | 1 | 2019 | 14 | 0.040 |
Why?
|
| Disease Progression | 1 | 2019 | 290 | 0.030 |
Why?
|
| Hyaluronan Synthases | 1 | 2017 | 2 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2017 | 9 | 0.030 |
Why?
|
| Fibrosis | 1 | 2017 | 15 | 0.030 |
Why?
|
| Hyaluronic Acid | 1 | 2017 | 23 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 8 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2017 | 11 | 0.030 |
Why?
|
| Hypertrophy | 1 | 2017 | 10 | 0.030 |
Why?
|
| Systole | 1 | 2017 | 10 | 0.030 |
Why?
|
| Collagen | 1 | 2017 | 44 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 28 | 0.030 |
Why?
|
| Heart Ventricles | 1 | 2017 | 50 | 0.030 |
Why?
|
| Hyperesthesia | 1 | 2015 | 1 | 0.030 |
Why?
|
| Claudin-3 | 1 | 2015 | 1 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 2015 | 2 | 0.030 |
Why?
|
| Claudin-1 | 1 | 2015 | 2 | 0.030 |
Why?
|
| Transgenes | 1 | 2015 | 4 | 0.030 |
Why?
|
| Tight Junctions | 1 | 2015 | 8 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2015 | 18 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2015 | 15 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 19 | 0.030 |
Why?
|
| Homeostasis | 1 | 2015 | 35 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2015 | 46 | 0.030 |
Why?
|
| Seizures | 1 | 2015 | 35 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2015 | 14 | 0.030 |
Why?
|
| Cytokines | 1 | 2015 | 107 | 0.030 |
Why?
|
| Ataxia | 1 | 2015 | 51 | 0.030 |
Why?
|
| Cell Survival | 1 | 2015 | 46 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 247 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 125 | 0.030 |
Why?
|
| Inflammation | 1 | 2015 | 124 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 105 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2015 | 246 | 0.020 |
Why?
|
| Proteolysis | 1 | 2013 | 4 | 0.020 |
Why?
|
| Granzymes | 1 | 2013 | 6 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 29 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 15 | 0.020 |
Why?
|
| Cations | 1 | 2013 | 12 | 0.020 |
Why?
|
| Transfection | 1 | 2013 | 59 | 0.020 |
Why?
|
| Models, Animal | 1 | 2013 | 74 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2013 | 157 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2011 | 2 | 0.020 |
Why?
|
| Clathrin | 1 | 2011 | 3 | 0.020 |
Why?
|
| GTP Phosphohydrolases | 1 | 2011 | 3 | 0.020 |
Why?
|
| Brain | 1 | 2015 | 707 | 0.020 |
Why?
|
| Adult | 1 | 2015 | 3557 | 0.020 |
Why?
|
| rho-Specific Guanine Nucleotide Dissociation Inhibitors | 1 | 2007 | 2 | 0.020 |
Why?
|
| Middle Aged | 1 | 2015 | 4043 | 0.020 |
Why?
|
| Aged | 1 | 2015 | 4000 | 0.020 |
Why?
|
| Helminth Proteins | 1 | 2005 | 4 | 0.010 |
Why?
|
| Gram-Negative Bacteria | 1 | 2005 | 12 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 2005 | 13 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 22 | 0.010 |
Why?
|
| Oxidants | 1 | 2005 | 14 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2005 | 51 | 0.010 |
Why?
|
| Edema | 1 | 2005 | 15 | 0.010 |
Why?
|
| Protein Binding | 1 | 2005 | 70 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2005 | 30 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2005 | 69 | 0.010 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2003 | 2 | 0.010 |
Why?
|
| Qb-SNARE Proteins | 1 | 2003 | 2 | 0.010 |
Why?
|
| Qc-SNARE Proteins | 1 | 2003 | 2 | 0.010 |
Why?
|
| Dynamins | 1 | 2003 | 3 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 2003 | 5 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2003 | 17 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 47 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 44 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 225 | 0.010 |
Why?
|